Life Sciences

Southport Innovation Center

MORRISVILLE, N.C. — Trinity Capital Advisors has signed a 25,972-square-foot lease with Enzyvant at Southport Innovation Center, a 95-acre life sciences and technology campus in Morrisville. Enzyvant, a Cambridge, Mass.-based biotech company focusing on tissue-based regenerative therapies, is slated to occupy 50 percent of 101 Southcenter Court. With the new tenant, Southport Innovation Center is 87 percent leased. The new space at Southport Innovation Center will have customized labs and offices, including clean rooms for the manufacturing of Enzyvant’s recently approved tissue-based regenerative therapy. Southport Innovation Center features 17 buildings totaling 911,700 square feet of space. The buildings are a mix of lab, office and flex buildings. Property amenities include a fitness center and locker rooms, lounge, bar and café, conference center and an outdoor gathering space.

FacebookTwitterLinkedinEmail
University of Alabama

BIRMINGHAM, ALA. — Hoar Construction has topped out Phase I of the new Science and Engineering Complex at the University of Alabama at Birmingham (UAB). The $76 million, 138,842-square-foot development represents Phase I of a three-part project that aims to consolidate all the basic science undergraduate and graduate studies into one complex. Construction of Phase I began in February 2021 and is expected to be completed in the spring of 2023. The first phase of the concrete structure features four levels that will house biology, chemistry and physics labs and classrooms alongside faculty and staff offices. The project will also feature specialized labs, including an optics lab and cold-growth environment rooms. Collaboration spaces will be designed to allow students across different disciplines and levels of education to mingle and work together in a cohesive learning environment. Located on 14th Street South between University Boulevard and 10th Avenue South, the property is situated 1.6 miles from downtown Birmingham. Additional project partners include Goodwyn, Mills & Cawood as lead architect; Lord Aeck Sargent as lab and research spaces consultant; MBA Engineers as structural engineers; Schoel Engineering as civil engineers; Newcomb & Boyd as mechanical engineers; and Hyde Engineering as electrical engineers.

FacebookTwitterLinkedinEmail

MANHATTAN, KAN. — Scorpion Biological Services, a subsidiary of Heat Biologics Inc., is building a new 500,000-square-foot biomanufacturing facility in Manhattan. The $650 million project will create 500 new jobs in the area within the next seven years, according to Gov. Laura Kelly. The facility will support the development of vaccines that enable an accelerated response to global biological threats. The company also intends to provide commercial level development, manufacturing and bioanalytical testing services at every stage for biopharmaceutical products on a fee-for-service basis to the global healthcare industry. The project came together as a result of partnerships between the Kansas Department of Commerce, Kansas State University, Kansas State University Innovation Partners, the City of Manhattan, the Manhattan Chamber of Commerce, Pottawatomie County, Pottawatomie County Economic Development Corp., Manhattan Area Technical College, Evergy, CRB and Realty Trust Group. A timeline for construction was not provided.

FacebookTwitterLinkedinEmail

SAN CARLOS, CALIF. — Square Mile Capital Management has originated a $118 million loan to finance the development of 777 Industrial Road, a planned R&D and life sciences lab building in the Bay Area city of San Carlos. The borrower is a partnership managed by Presidio Bay Ventures, which purchased the former car dealership site in 2020. The project team plans to develop a four-story, 150,000-square-foot, Class A building on top of an existing parking podium at the site. The property will feature lab buildouts, a fitness center with full locker rooms, a 4,000-square-foot rooftop deck and ample outdoor seating. Jeff Wilcox of Gantry arranged the financing.

FacebookTwitterLinkedinEmail

WILMINGTON, MASS. — Boston-based mortgage banking firm EagleBridge Capital has arranged $38 million in debt and joint venture equity financing for a 210,945-square-foot office and lab complex in the northern Boston suburb of Wilmington. Located at 181 and 187 Ballardvale St., the two buildings sit on a combined 15.4 acres and each span approximately 105,000 square feet. Ted Sidel and Brian Walsh arranged the financing, specific terms of which were not disclosed, on behalf of an unnamed borrower.

FacebookTwitterLinkedinEmail
Denny-Park-South-Seattle

SEATTLE — BioMed Realty, a San Diego-based owner-operator of healthcare real estate and a Blackstone portfolio company, has acquired a life sciences development site in Seattle. The sales price was $127 million, according to The Puget Sound Business Journal. BioMed plans to develop 616,000 square feet of life sciences space at the site, which is known as Denny Park South and comprises two adjacent parcels totaling 1.6 acres in South Lake Union/Denny Triangle neighborhood. The location is also near a variety of healthcare facilities and research institutions, notes Jon Bergschneider, president of West Coast markets at BioMed Realty. “The South Lake Union/Denny Triangle cluster is flush with renowned research institutes like the University of Washington School of Medicine, Gates Foundation, Fred Hutchinson Cancer Research Center and the Allen Institute, as well as large tech users such as Amazon, Meta and Apple,” he says. Following this development, BioMed’s life sciences portfolio in Seattle, which includes the recently completed flagship Dexter Yard project in South Lake Union, will total approximately 1.8 million square feet. A tentative construction timeline for the Denny Park South project was not disclosed. The acquisition of Denny Park South follows BioMed’s purchase of T6 Innovation Center, located at …

FacebookTwitterLinkedinEmail
690-Canton-St.-Westwood-Massachusetts

WESTWOOD, MASS. — A partnership between two New York City-based investment firms, Outshine Properties and Jadian Capital, has acquired a 164,695-square-foot office building in the southern Boston suburb of Westwood with plans to convert the property to a life sciences facility. The sales price was $32 million. The four-story building is currently 73 percent leased to seven tenants. Robert Griffin, Edward Maher, Matthew Pullen and Samantha Hallowell of Newmark represented the seller, L&B Realty Advisors, in the transaction. William Sleeper, also with Newmark, arranged acquisition financing for the deal through J.P. Morgan. The new ownership expects to deliver 140,000 square feet of prebuilt lab space in the second quarter of 2023.

FacebookTwitterLinkedinEmail
5000-Shoreline-South-San-Francisco-CA

SOUTH SAN FRANCISCO, CALIF. — DivcoWest has purchased 5000 Shoreline, a three-story, Class A office building located on 8.5 waterfront acres at 5000 Shoreline Court in South San Francisco. The buyer plans to convert the property, which is vacant, into a life sciences asset. The seller was not disclosed. DivcoWest plans to upgrade the base building improvements, utilities, electrical and mechanical components, and covert the existing structure to a warm shell condition to accommodate life sciences tenancy. Once base building modifications are complete, DivcoWest plans to complete market-ready upgrades to the interiors to be able to offer prospective tenants turn-key office and laboratory suites. Mike Walker and Brad Zampa of CBRE Capital Markets’ Debt & Structured Finance group arranged $124 million in acquisition and conversion financing for DivcoWest. The three-year, nonrecourse, floating-rate loan was secured through a European investment bank.

FacebookTwitterLinkedinEmail
Flatiron-Park-Boulder-Colorado

BOULDER, COLO. — BioMed Realty, a San Diego-based owner-operator of healthcare real estate and a Blackstone portfolio company, has acquired Flatiron Park, a 1 million-square-foot office and life sciences campus in Boulder, a northwestern suburb of Denver. The sales price was not disclosed, but The Wall Street Journal reports that BioMed Realty paid more than $600 million for the property. JLL represented the seller, a joint venture between Crescent Real Estate, Goldman Sachs Asset Management and Lionstone Investments, in the transaction. BioMed Realty plans to invest about $200 million in capital improvements to the campus, an endeavor that is expected to create about 400 local construction jobs. Flatiron Park consists of 22 buildings that were approximately 90 percent leased at the time of sale. The buildings range in size from approximately 15,000 to 133,000 square feet. BioMed officials say that the campus will “anchor” its presence in the greater Denver area, which the company says has an exceptionally talented workforce “Boulder has always been a market to watch, driven by highly educated talent, robust capital flow, an existing base of life sciences and tech pioneers and great quality of life,” says Mike Ruhl, vice president of leasing at BioMed Realty. …

FacebookTwitterLinkedinEmail
100-Binney-Street-Boston

BOSTON — CBRE Investment Management has acquired a partial interest in 100 Binney, a 432,932-square-foot life sciences building in Boston’s Kendall Square neighborhood. The percentage of the interest was not disclosed. The 10-story building was constructed in 2018 and was fully leased at the time of the sale, with pharmaceutical giant Bristol Myers Squibb serving as the anchor tenant. Robert Griffin, Edward Maher, Matthew Pullen and Samantha Hallowell of Newmark represented the undisclosed building owner/seller in the recapitalization deal and procured CBRE Investment Management as the buyer.

FacebookTwitterLinkedinEmail